These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17368747)

  • 1. Potentiation of anti-epileptic drugs effectiveness by pyronaridine in refractory epilepsy.
    Asadi-Pooya AA; Sperling MR
    Med Hypotheses; 2007; 69(3):560-3. PubMed ID: 17368747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of p38 mitogen-activated protein kinase signaling reduces multidrug transporter activity and anti-epileptic drug resistance in refractory epileptic rats.
    Shao Y; Wang C; Hong Z; Chen Y
    J Neurochem; 2016 Mar; 136(5):1096-105. PubMed ID: 26677173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions.
    Lazarowski A; Czornyj L
    Drug Metabol Drug Interact; 2011; 26(1):21-6. PubMed ID: 21557674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.
    Kwan P; Brodie MJ
    Epilepsia; 2005 Feb; 46(2):224-35. PubMed ID: 15679503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transport of antiepileptic drugs by P-glycoprotein.
    Zhang C; Kwan P; Zuo Z; Baum L
    Adv Drug Deliv Rev; 2012 Jul; 64(10):930-42. PubMed ID: 22197850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of tetrandrine on refractory epilepsy via suppressing P-glycoprotein.
    Chen Y; Xiao X; Wang C; Jiang H; Hong Z; Xu G
    Int J Neurosci; 2015; 125(9):703-10. PubMed ID: 25233150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.
    van Vliet EA; van Schaik R; Edelbroek PM; Redeker S; Aronica E; Wadman WJ; Marchi N; Vezzani A; Gorter JA
    Epilepsia; 2006 Apr; 47(4):672-80. PubMed ID: 16650133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients.
    Mosyagin I; Runge U; Schroeder HW; Dazert E; Vogelgesang S; Siegmund W; Warzok RW; Cascorbi I
    Epilepsia; 2008 Sep; 49(9):1555-61. PubMed ID: 18494787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy.
    Brandt C; Bethmann K; Gastens AM; Löscher W
    Neurobiol Dis; 2006 Oct; 24(1):202-11. PubMed ID: 16928449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug transporters in the epileptic brain.
    Löscher W
    Epilepsia; 2007; 48 Suppl 1():8-13. PubMed ID: 17316407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.
    Schmidt D; Löscher W
    Epilepsia; 2005 Jun; 46(6):858-77. PubMed ID: 15946327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of drug resistance.
    Löscher W
    Epileptic Disord; 2005 Sep; 7 Suppl 1():S3-9. PubMed ID: 16120487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine.
    Marchi N; Guiso G; Rizzi M; Pirker S; Novak K; Czech T; Baumgartner C; Janigro D; Caccia S; Vezzani A
    Epilepsia; 2005 Oct; 46(10):1613-9. PubMed ID: 16190932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanisms of medically refractory temporal lobe epilepsy.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2009 Sep; 18(3):155-60. PubMed ID: 19960958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.
    Löscher W; Potschka H
    J Pharmacol Exp Ther; 2002 Apr; 301(1):7-14. PubMed ID: 11907151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery.
    Liu J; He Y; Zhang J; Li J; Yu X; Cao Z; Meng F; Zhao Y; Wu X; Shen T; Hong Z
    Biomaterials; 2016 Jan; 74():64-76. PubMed ID: 26447556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function and mechanism of pyronaridine: a new inhibitor of P-glycoprotein-mediated multidrug resistance.
    Qi J; Yang CZ; Wang CY; Wang SB; Yang M; Wang JH
    Acta Pharmacol Sin; 2002 Jun; 23(6):544-50. PubMed ID: 12060530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot double-blind trial using verapamil as adjuvant therapy for refractory seizures.
    Borlot F; Wither RG; Ali A; Wu N; Verocai F; Andrade DM
    Epilepsy Res; 2014 Nov; 108(9):1642-51. PubMed ID: 25223728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Approach to Refractory Epilepsy by Targeting Pgp Peripherally and Centrally: Therapeutic Targets and Future Perspectives.
    Langeh U; Chawla P; Gupta GD; Singh S
    CNS Neurol Disord Drug Targets; 2020; 19(10):741-749. PubMed ID: 32814543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis.
    Kubota H; Ishihara H; Langmann T; Schmitz G; Stieger B; Wieser HG; Yonekawa Y; Frei K
    Epilepsy Res; 2006 Mar; 68(3):213-28. PubMed ID: 16361082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.